New award for atropine/diphenoxylate HCL tablets with specgx, LLC . Period of performance is may 27, 2023 through may 26, 2024 with four one year option years.

Active Indefinite Delivery Contract Awarded Last action

Contract number
36E79723D0016
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 86% complete
IDV ceiling
$1,388,323.80
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The National Acquisition Center awarded a single-award indefinite delivery contract to Specgx LLC for atropine/diphenoxylate HCL tablets on May 27, 2023, with a ceiling of $1,388,323.80.

The contract runs from May 27, 2023 through May 26, 2024, with four one-year option periods extending the ultimate completion date to May 26, 2027. The originating solicitation was posted November 18, 2022 with a due date of November 28, 2022. This is a full-and-open procurement with no set-aside applied.

Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, is a pharmaceutical manufacturer headquartered in Webster Groves, Missouri, that supplies controlled substance medications to federal healthcare agencies. The company operates manufacturing facilities in Webster Groves and Hobart, New York.

A modification to the contract effective April 2026 incorporated Section 5 of Executive Order 14398, Clause 52.222-90, addressing diversity, equity, and inclusion requirements and discrimination prohibitions applicable to federal contractors.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00010 · This modification incorporates section 5 of EO 14398, clause 52.222-90, addressing DEI discrimination by federal contractors (APR 2026), into existing… $0
Exercise an Option P00009 · Exercise 3RD option year for atropine/diphenoxylate HCL tablets, effective may 27, 2026 through may 26, 2027 with no price changes $0
Add Subcontract Plan P00008 · Incorporate specgx 2026 subcontracting plan for atropine/diphenoxylate HCL tablets with specgx, LLC effective january 1, 2026 through december 31, 2026. $0
Exercise an Option P00007 · Exercise option year 2 for atropine/diphenoxylate HCL tablets with specgx, LLC effective may 27, 2025 through may 26, 2026. Prices remain unchanged. $0
Add Subcontract Plan P00006 · Revised 2025 subcontractin plan for atropine/diphenoxylate HCL tablets with specgx, LLC effective 1/1/2025 through 12/31/2025. Prices remain unchanged. $0
Add Subcontract Plan P00005 · 2025 subcontractin plan for atropine/diphenoxylate HCL tablets with specgx, LLC effective 1/1/2025 through 12/31/2025. Prices remain unchanged. $0
Exercise an Option P00004 · Exercise option year one for atropine/diphenoxylate HCL tablets with specgx, LLC effective 5/27/2024 through 5/26/2025. Prices remain unchanged. $0
Add Subcontract Plan P00003 · 2024 subcontracting plan for atropine/diphenoxylate HCL tablets with specgx, LLC effective 1/1/2024-12/31/2024 $0
Other Administrative Action P00002 · Cost recovery fee and submission of quarterly sales report for atropine/diphenoxylate HCL tablets with specgx, LLC effective 2/9/2024. $0
Other Administrative Action P00001 · Incorporate dscsa for atropine/diphenoxylate HCL tablets with specgx, LLC effective 5/15/2023. $0
Original award $0
Show all 11

Quick answers

Who was awarded contract 36E79723D0016?

36E79723D0016 was awarded to Specgx LLC by National Acquisition Center (Headquarters) on May 27, 2023.

How much is contract 36E79723D0016 worth?

36E79723D0016's own ceiling is $1,388,324.

Who can order from contract 36E79723D0016?

36E79723D0016 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 36E79723D0016 competed?

The extent of competition for 36E79723D0016 was full and open competition. The government received 4 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV